Last viewed: ORIC


Prices are updated after-hours



nasdaq:ORIC Oric Pharmaceuticals, Inc.

ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-35.6% 1m) (64.3% 1y) (0.0% 2d) (-0.9% 3d) (-5.5% 7d) (-38.66% volume)
Earnings Calendar: 2024-03-14
Market Cap: $ 659,609,542

http://www.oricpharma.com
Sec Filling | Patents | 57 employees


(US) Oric Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

cancer   hormone   treatment   cancer treatments  

add to watch list Paper trade email alert is off

Press-releases


ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| | O: -1.05% H: 2.75% C: 0.11%

oric-114 first pharmaceuticals expansion trial
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
LLY | News | $750.77 0.54% -0.04% 3.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.71% H: 0.0% C: 0.0%
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| | O: -2.81% H: 1.54% C: -3.57%
NRIX 1 d | $14.1 -3.75% -3.9% 970K twitter stocktwits trandingview |
Health Technology
| | O: 18.35% H: 1.98% C: -5.88%

therapeutics
ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| | O: -1.25% H: 0.0% C: -2.71%

association cancer pharmaceuticals research preclinical for meeting
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-05 (Crawled : 21:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq pharmaceuticals grants
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Published: 2024-04-04 (Crawled : 21:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%

pharmaceuticals
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
Published: 2024-03-11 (Crawled : 20:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| | O: -2.4% H: 3.01% C: -2.12%

year pharmaceuticals financial results
ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
Published: 2024-03-06 (Crawled : 22:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| | O: 0.62% H: 1.43% C: -1.36%

conference biopharma pharmaceuticals
ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 22:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| | O: 1.42% H: 5.98% C: 2.04%

association cancer pharmaceuticals research meeting
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-01 (Crawled : 22:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq pharmaceuticals
ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit
Published: 2024-02-14 (Crawled : 22:00) - globenewswire.com
ORIC | $9.79 3.6% 3.47% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 4.66% C: 2.83%

pharmaceuticals
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K twitter stocktwits trandingview |
Technology Services
| 00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M twitter stocktwits trandingview |
Finance
| 22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K twitter stocktwits trandingview |
Retail Trade
| 22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K twitter stocktwits trandingview |
Energy Minerals
| 21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M twitter stocktwits trandingview |
Health Technology
| 16:30
RMCF | $3.51 -3.7% -3.85% 3.8K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar